Explore what makes us unique
ABX-CRO has selected Flex Databases CTMS and eTMF to further increase quality of clinical trial management
Speaking about why ABX-CRO decided to choose Flex Databases, Dr. Ulrike Schorr-Neufing said: The possibility of on-premise solutions for CTMS and eTMF as well as the flexibility of the different modules for managing clinical trials suits ABX-CRO very well. Flex...
ABX-CRO (Dresden, Germany), the globally leading full-service CRO for molecular imaging and radiotherapy, ONCODESIGN (ALONC -FR0011766229), a French biopharmaceutical company dedicated to precision medicine, Covalab (Bron, France), a biotechnology company specializing in the development and production of custom antibodies and CheMatech (Dijon, France), the European leader in the design announce their partnership. This strategic collaboration will launch the DRIVE™-MRT (Molecular RadioTherapy) solution. This innovative, premium service offer for therapeutic development is unique in nuclear medicine; it encompasses the full drug discovery process of theranostics, from therapeutic target validation, radiolabeled biological vector generation, lead optimization, preclinical candidate drug generation and IND, to the design and management of clinical trials.